Literature DB >> 20811369

Deal watch: Infinity and Intellikine to develop oral PI3K inhibitors for inflammatory diseases.

.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20811369     DOI： 10.1038/nrd3256

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors.

Authors:  Alex Berndt; Simon Miller; Olusegun Williams; Daniel D Le; Benjamin T Houseman; Joseph I Pacold; Fabrice Gorrec; Wai-Ching Hon; Yi Liu; Christian Rommel; Pascale Gaillard; Thomas Rückle; Matthias K Schwarz; Kevan M Shokat; Jeffrey P Shaw; Roger L Williams
Journal:  Nat Chem Biol       Date:  2010-02       Impact factor: 15.040
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.